The CF gastrointestinal microbiome: Structure and clinical impact

Geraint Rogers, Michael Narkewicz, Lucas Hoffman

Research output: Contribution to journalReview articlepeer-review

21 Citations (Scopus)


The gastrointestinal (GI) microbiome is shaped by host diet, immunity, and other physicochemical characteristics of the GI tract, and perturbations such as antibiotic treatments can lead to persistent changes in microbial constituency and function. These GI microbes also play critical roles in host nutrition and health. A growing body of evidence suggests that the GI microbiome in people with CF is altered, and that these dysbioses contribute to disease manifestations in many organs, both within and beyond the GI tract. Therapies that people with CF receive, even those targeting the respiratory tract, may impact the CF GI microbiome in ways that can influence the outcome of treatment. These new perspectives on the microbial contents of the CF intestine offer new opportunities for preventing a variety of CF-associated disorders. Pediatr Pulmonol. 2016;51:S35–S44.

Original languageEnglish
Pages (from-to)S35-S44
Number of pages10
JournalPediatric Pulmonology
Issue numberS44
Early online date23 Sept 2016
Publication statusPublished - 1 Oct 2016


  • gastrointestinal microbiome
  • GI tract
  • microbes
  • cystic fibrosis
  • gastrointestinal
  • antibiotic therapy
  • cystic fibrosis (CF)
  • microbiome


Dive into the research topics of 'The CF gastrointestinal microbiome: Structure and clinical impact'. Together they form a unique fingerprint.

Cite this